Enas I El Zahaby

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsCharacterisation of biological macromoleculesInjury preventionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2025
Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming.

Neveen R Ashoura, Hebatallah M Saad, Enas I El Zahaby

|Jan 08, 2025
Investigating the Antibacterial, Antioxidant, and Anti-Inflammatory Properties of a Lycopene Selenium Nano-Formulation: An In Vitro and In Vivo Study.

Reem Binsuwaidan, Thanaa A El-Masry, Maysa M F El-Nagar

|Sep 28, 2024
Hesperidin Nanoformulation: A Potential Strategy for Reducing Doxorubicin-Induced Renal Damage via the Sirt-1/HIF1-α/VEGF/NF-κB Signaling Cascade.

Fatemah A Alherz, Thanaa A El-Masry, Ghaleb A Oriquat

|Aug 29, 2024
Chitosan/Hesperidin Nanoparticles for Sufficient, Compatible, Antioxidant, and Antitumor Drug Delivery Systems.

May Almukainzi, Thanaa A El-Masry, Enas I El Zahaby

Pageof 1